To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.
Clinical trial NCT04542447 · UNKNOWN
Trial details
- NCT number
- NCT04542447
- Sponsor
- Natureceuticals Sdn Bhd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2020-09-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.